What HTSI Is About

HTSI is a community of leaders throughout the healthcare system focused on a common vision, “No patient will be harmed by medical technology.”  Its mission is “To engage the entire healthcare community in multi-disciplinary safety initiatives that strengthen the development, management, and use of technology for improved patient outcomes.”  

Safety issues surrounding healthcare technology deserve exclusive attention, and the AAMI Foundation’s HTSI is uniquely positioned to address them.   

At the core of the AAMI Foundation’s and HTSI’s philosophy is the belief that building consensus among healthcare stakeholders around the world can lead to the resolution of the most challenging and difficult issues facing the healthcare technology field.  Technology issues cannot be solved today by any single person, organization, or government working alone.  Therefore, HTSI seeks ways to foster interaction among all healthcare stakeholders to find solutions to safer technology. 

What We Do

The fast paced development and growth of healthcare technologies and related processes have incredible potential to improve patient outcomes, yet corresponding potential for unintended patient harm.  Therefore, HTSI strives to find ways to conduct research that uncovers new and better ways to use and design technologies, freely publish innovative studies  of leading healthcare institutions so that all of the healthcare community can learn new patient safety solutions, build consensus among stakeholders so that best practices can be standardized and widely adopted, close education gaps among clinicians and caregivers, and ultimately reduce errors resulting from the use of healthcare technology.  Read more.

How We Got Our Start

In May 2010, the U.S. Food and Drug Administration (FDA) held a two-day public workshop on infusion pumps that outlined the challenges and long-standing problems that the FDA and the healthcare community were encountering with these devices.  According to the FDA, over 56,000 adverse incidents had occurred in the last five years from infusion devices.  Many questions were raised during the workshop about design, human factors, and data collection but it was clear that more input from designers, users, clinicians, regulators, manufacturers, patient advocates, and others was needed in order to reduce incidents. As a result, AAMI and the FDA entered into a partnership to hold a Summit designed to facilitate extensive discussion among and between key stakeholders in order to set a clear direction for improving infusion pump safety. 

In October 2010, a remarkable group of thoughtful, committed, and diverse experts came together at the AAMI/FDA Infusion Device Summit.  The Summit opened with this quote from Margaret Mead: “Never doubt that a group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has.  Read more.